Prakash Peddi

3.3k total citations
33 papers, 560 citations indexed

About

Prakash Peddi is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Prakash Peddi has authored 33 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Cancer Research and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Prakash Peddi's work include Breast Cancer Treatment Studies (7 papers), DNA Repair Mechanisms (4 papers) and Colorectal Cancer Screening and Detection (3 papers). Prakash Peddi is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), DNA Repair Mechanisms (4 papers) and Colorectal Cancer Screening and Detection (3 papers). Prakash Peddi collaborates with scholars based in United States and Greece. Prakash Peddi's co-authors include Quyen D. Chu, Meijiao Zhou, Glenn Mills, Alexandros G. Georgakilas, David Francisco, Hazem El‐Osta, Xiao‐Cheng Wu, Samip Master, Rodney E. Shackelford and Gary V. Burton and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Prakash Peddi

32 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prakash Peddi United States 13 282 201 129 125 94 33 560
Yuichi Hisamatsu Japan 15 277 1.0× 211 1.0× 194 1.5× 128 1.0× 156 1.7× 33 631
Giulia Orsi Italy 12 220 0.8× 171 0.9× 148 1.1× 113 0.9× 115 1.2× 34 514
Volker Moebus Germany 15 393 1.4× 164 0.8× 97 0.8× 224 1.8× 93 1.0× 52 705
Bo Young Oh South Korea 17 456 1.6× 222 1.1× 173 1.3× 184 1.5× 182 1.9× 54 794
J. Yau United States 13 275 1.0× 270 1.3× 82 0.6× 108 0.9× 103 1.1× 19 700
Fabrício Henrique Pereira De Souza United States 6 218 0.8× 121 0.6× 112 0.9× 171 1.4× 225 2.4× 8 950
M.T. Allende Spain 13 165 0.6× 184 0.9× 150 1.2× 81 0.6× 72 0.8× 25 589
Tomoyo Yasui Japan 15 202 0.7× 263 1.3× 72 0.6× 156 1.2× 75 0.8× 58 637
Masayuki Otsuka Japan 15 300 1.1× 343 1.7× 121 0.9× 114 0.9× 227 2.4× 73 847
Ana Herrero Spain 14 217 0.8× 112 0.6× 125 1.0× 137 1.1× 86 0.9× 41 591

Countries citing papers authored by Prakash Peddi

Since Specialization
Citations

This map shows the geographic impact of Prakash Peddi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prakash Peddi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prakash Peddi more than expected).

Fields of papers citing papers by Prakash Peddi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prakash Peddi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prakash Peddi. The network helps show where Prakash Peddi may publish in the future.

Co-authorship network of co-authors of Prakash Peddi

This figure shows the co-authorship network connecting the top 25 collaborators of Prakash Peddi. A scholar is included among the top collaborators of Prakash Peddi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prakash Peddi. Prakash Peddi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dhaibar, Hemangini A., et al.. (2024). Real-world outcomes of sacituzumab govitecan in breast cancer.. Journal of Clinical Oncology. 42(16_suppl). e13137–e13137. 1 indexed citations
2.
Zhou, Meijiao, Prakash Peddi, & Quyen D. Chu. (2018). Radiation Therapy for Positive Surgical Margins in Women ≥70 Years with Stage I, Estrogen Receptor-positive Breast Cancer. Anticancer Research. 38(9). 5253–5260. 4 indexed citations
3.
Dherange, Parinita, et al.. (2018). CHARACTERISTICS OF CARDIOVASCULAR DISEASE IN CANCER PATIENTS: A CASE CONTROL STUDY. Journal of the American College of Cardiology. 71(11). A181–A181. 1 indexed citations
4.
5.
Sommerhalder, David, Amol Takalkar, Rodney E. Shackelford, & Prakash Peddi. (2017). Spontaneous tumor lysis syndrome in colon cancer: a case report and literature review. Clinical Case Reports. 5(12). 2121–2126. 22 indexed citations
6.
Takalkar, Amol, et al.. (2017). Follicular dendritic sarcoma masquerading as fibrosing mediastinitis. BMJ Case Reports. 2017. bcr–2016. 8 indexed citations
7.
Veillon, Diana M., et al.. (2017). Reversal of isolated 20q deletion with vitamin B12 replacement in a patient with pernicious anaemia. BMJ Case Reports. 2017. bcr2016218689–bcr2016218689. 2 indexed citations
8.
Gupta, Ankita, et al.. (2017). Primary brain tumor and risk of venous thromboembolism.. Journal of Clinical Oncology. 35(15_suppl). e13518–e13518. 1 indexed citations
9.
10.
Peddi, Prakash, et al.. (2017). Clinical Review: Management of Adult Kasabach-Merritt Syndrome Associated with Hemangiomas. Journal of Blood Disorders & Transfusion. 8(5). 3 indexed citations
11.
Chu, Quyen D., Meijiao Zhou, Prakash Peddi, et al.. (2017). Influence of facility type on survival outcomes after pancreatectomy for pancreatic adenocarcinoma. HPB. 19(12). 1046–1057. 25 indexed citations
12.
13.
Peddi, Prakash, et al.. (2016). Regression of a glioblastoma multiforme: spontaneous versus a potential antineoplastic effect of dexamethasone and levetiracetam. BMJ Case Reports. 2016. bcr2016217393–bcr2016217393. 10 indexed citations
14.
Shi, Zhenzhen, Prakash Peddi, Gary V. Burton, Glenn Mills, & Runhua Shi. (2016). Effect of Postmastectomy Radiation on Survival of AJCC pN2/N3 Breast Cancer Patients.. PubMed. 36(1). 261–9. 10 indexed citations
15.
El‐Osta, Hazem, et al.. (2016). Immune checkpoint inhibitors: the new frontier in non–small cell lung cancer treatment. OncoTargets and Therapy. Volume 9. 5101–5116. 24 indexed citations
16.
17.
El‐Osta, Hazem, et al.. (2016). Exceptional response to cetuximab monotherapy in a patient with metastatic oropharyngeal squamous cell carcinoma: a molecular insight. OncoTargets and Therapy. 9. 705–705. 6 indexed citations
18.
Peddi, Prakash, et al.. (2015). Cisplatin, Cetuximab, and Radiation in Locally Advanced Head and Neck Squamous Cell Cancer: A Retrospective Review. Clinical Medicine Insights Oncology. 9. 1–7. 17 indexed citations
19.
Peddi, Prakash, Jennifer S. Dickey, Khaled Aziz, et al.. (2010). DNA-PKcs deficiency leads to persistence of oxidatively induced clustered DNA lesions in human tumor cells. Free Radical Biology and Medicine. 48(10). 1435–1443. 59 indexed citations
20.
Peddi, Prakash, et al.. (2008). Processing of clustered DNA damage in human breast cancer cells MCF-7 with partial DNA-PKcs deficiency. Cancer Letters. 269(1). 174–183. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuichi Hisamatsu Breakdown of academic impact, for papers by Giulia Orsi Breakdown of academic impact, for papers by Volker Moebus Breakdown of academic impact, for papers by Bo Young Oh Breakdown of academic impact, for papers by J. Yau Breakdown of academic impact, for papers by Fabrício Henrique Pereira De Souza Breakdown of academic impact, for papers by M.T. Allende Breakdown of academic impact, for papers by Tomoyo Yasui Breakdown of academic impact, for papers by Masayuki Otsuka Breakdown of academic impact, for papers by Ana Herrero
Rankless by CCL
2026